Research Topics
| Emmanuelle CauchetierSummaryCountry: France Publications
| Collaborators |
Detail Information
Publications
Characterisation of atovaquone resistance in Leishmania infantum promastigotesE Cauchetier
Laboratoire de Pharmacotechnie, Service Pharmacie, C H U H Mondor, AP HP, 94010 Creteil, France
Int J Parasitol 32:1043-51. 2002..These results indicate that different cellular alterations may participate in the resistant phenotype, by altering drug membrane permeability...
Atovaquone-loaded nanocapsules: influence of the nature of the polymer on their in vitro characteristicsEmmanuelle Cauchetier
Laboratoire de Pharmacotechnie, Service Pharmacie, C H U Henri MONDOR, 94010 Creteil, France
Int J Pharm 250:273-81. 2003..9%) was found with PLA nanoparticles at 4 months. Release of both atovaquone (18.9%) and benzylbenzoate (54.2%) was noted with PLAGA nanoparticles from the third month, indicating a disruption of the nanoparticle membrane...
Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the treatment of murine visceral leishmaniasisE Cauchetier
Laboratoire de Pharmacotechnie, Service Pharmacie, Centre Hospitalier Universitaire Henri Mondor, Assistance Publique Hopitaux de Paris, 94010 Creteil, France
Ann Trop Med Parasitol 97:259-68. 2003....
